CUA Educational Content

CUA Guideline on Androgen Deprivation Therapy: Adverse Events and Management Strategies [UPDATE 2022]

EDITORIAL COMMITTEE: Fred Saad, Ricardo Rendon, Armen Aprikian, Andrew Feifer, Andrea Kokorovic


By participating in this educational session, health care providers can expect to:

  • Summarize the major adverse events (AEs) associated with conventional androgen deprivation therapy (ADT)
  • Review the evidence-based strategies to mitigate the AEs associated with ADT in men with prostate cancer (PC)
Start Quiz for Credits

ACCREDITATION

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Urological Association. You may claim a maximum of 1.5 hours of credit.

​This program was made possible with financial support from Tolmar.

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy